Holen Sie sich die Stockscreener-App
25.18
2.34%
0.415
Schlusskurs vom Vortag:
$24.77
Offen:
$25
24-Stunden-Volumen:
53,656
Relative Volume:
0.23
Marktkapitalisierung:
$988.61M
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
68.07
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
+5.80%
1M Leistung:
+9.08%
6M Leistung:
+17.14%
1J Leistung:
+44.53%
1-Tages-Spanne:
$24.72
$25.36
1-Wochen-Bereich:
$23.57
$25.36
52-Wochen-Spanne:
$16.16
$26.55
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
25.19 | 988.61M | 982.01M | 14.80M | 37.02M | 0.37 |
|
RGC
Regencell Bioscience Holdings Ltd
|
23.78 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
157.40 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.44 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.94 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.98 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Reasons to Add PAHC Stock to Your Portfolio Right Now - Yahoo Finance
GAMMA Investing LLC Has $784,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World
Phibro Animal Health (NASDAQ:PAHC) Upgraded to “Neutral” at BNP Paribas Exane - Defense World
Zacks.com featured highlights include Popular, Affiliated Managers, Astronics and Phibro Animal Health - The Globe and Mail
Phibro Animal Health upgraded to Neutral from Underperform at BNP Paribas Exane - TipRanks
Phibro Animal Health (PAHC) Rating Upgraded by Analyst | PAHC Stock News - GuruFocus
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Bank of America Corp DE Cuts Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Zacks.com featured highlights Urban Outfitters, Phibro Animal Health and Strattec Security - Yahoo Finance
3 Stocks Showing Positive Momentum Despite Trade Tensions - Yahoo Finance
Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Jane Street Group LLC Trims Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Deutsche Bank AG Boosts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Ameriprise Financial Inc. Purchases 21,576 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Millennium Management LLC Has $4.36 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro at Stifel Jaws & Paws Conference: Strategic Growth and Challenges - Investing.com India
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Purchased by Lazard Asset Management LLC - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by BNP Paribas Financial Markets - Defense World
D. E. Shaw & Co. Inc. Trims Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Best Value Stocks to Buy for May 23rd - Yahoo Finance
Phibro Animal Health COO and Strategy Chief Set to Reveal Business Updates at Stifel Conference - Stock Titan
What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Northern Trust Corp - Defense World
Solid Earnings Reflect Phibro Animal Health's (NASDAQ:PAHC) Strength As A Business - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
International Markets and Phibro (PAHC): A Deep Dive for Investors - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2025 Earnings Call Transcript - Insider Monkey
Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth - TipRanks
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at StockNews.com - Defense World
Phibro Animal Health (NASDAQ:PAHC) Shares Gap Down – Time to Sell? - Defense World
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12 - Yahoo Finance
Phibro Animal Health (PAHC) Target Price Raised to $21 by Morgan Stanley | PAHC Stock News - GuruFocus
Phibro Animal Health Co. (NASDAQ:PAHC) Stake Trimmed by Dimensional Fund Advisors LP - Defense World
Phibro Animal Health (NASDAQ:PAHC) Trading 12.6% Higher Following Better-Than-Expected Earnings - Defense World
Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
Phibro Animal Health Corp. Reaches Analyst Target Price - Nasdaq
Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and Strategic Investments Propel Performance - GuruFocus
Earnings call transcript: Phibro Animal Health beats Q3 2025 expectations - Investing.com
Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge By Investing.com - Investing.com South Africa
Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge - Investing.com Canada
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $21 From $20, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Phibro Animal Health (PAHC) Price Target Following Q3 Performance | PAHC Stock News - GuruFocus
Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised - Yahoo Finance
Envestnet Asset Management Inc. Buys New Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phibro Animal Health Corp-Aktie (PAHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CORCORAN E THOMAS | Director |
Feb 24 '25 |
Buy |
22.10 |
5,000 |
110,500 |
30,000 |
1.74%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):